Indeed, inactivation of ACKR2 in gene-targeted animals causes tumor-promoting inflammation in the skin and the gastrointestinal tract [21,22] and a similar observation was made in Kaposi’s sarcoma, where ACKR2 expression is downregulated by the oncogenic KRAS pathway [23]. This evidence concerns the gene ACKR2 and Kaposi's sarcoma.